KingMed Diagnostics

KingMed Diagnostics is one of the...

• CSI 500.

KingMed Diagnostics is a company listed under the stock ticker 603882 (CN).

View the org chart displaying its 2 main executives

Most searched biographies at KingMed Diagnostics

• Yaoming Liang, Chief Executive Officer
• Bi Xi, Chief Financial Officer, Secretary, Director and Deputy Gen...

Create your alert
to follow the executive moves at KingMed Diagnostics.

KingMed Diagnostics has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by KingMed Diagnostics

Social media about KingMed Diagnostics

• KingMed Diagnostics on Wikipedia, Google News & Yahoo Finance
• KingMed Diagnostics on LinkedIn, Twitter & YouTube

Call KingMed Diagnostics at +86 202...

View the org chart

Register to receive your alert

Report an error